CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP)
Clinical trials for CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP) trials appear
Sign up with your email to follow new studies for CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take aim at debilitating brain and nerve diseases
Disease control Recruiting nowThis early-phase study is testing a new treatment called universal CAR-T cells (RD06-05) in up to 36 adults with relapsing or refractory multiple sclerosis, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, or autoimmune encephalitis. The therapy uses speciall…
Matched conditions: CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP)
Phase: EARLY_PHASE1 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Experimental cell therapy targets tough autoimmune conditions
Disease control Recruiting nowThis early-stage study tests a new cell therapy called QH103 in up to 6 people with relapsed or hard-to-treat autoimmune diseases like multiple sclerosis and myasthenia gravis. The therapy uses specially engineered immune cells to target and calm the overactive immune system. The…
Matched conditions: CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP)
Phase: PHASE1 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated May 22, 2026 13:55 UTC
-
New treatment option opens for CIDP patients who have no other choices
Disease control AVAILABLEThis program provides efgartigimod PH20 SC to adults with CIDP who cannot join a clinical trial and have not been helped by standard treatments like steroids or immunoglobulins. The goal is to control the disease by reducing nerve inflammation. Treatment continues until the patie…
Matched conditions: CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP)
Sponsor: argenx • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Scientists probe nerve signals to unravel rare nerve diseases
Knowledge-focused Recruiting nowThis study aims to learn more about how nerves work in people with Charcot-Marie-Tooth disease and other nerve disorders like CIDP. Researchers will use special electrical tests and ultrasound to measure nerve responses and structure. The study involves 39 adults and does not tes…
Matched conditions: CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP)
Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta • Aim: Knowledge-focused
Last updated May 18, 2026 12:04 UTC